STRATA Skin Sciences Inc [SSKN] stock prices are up 4.00% to $2.08 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SSKN shares have gain 20.23% over the last week, with a monthly amount glided 49.64%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Oppenheimer started tracking the stock with Outperform rating on November 21, 2019, and set its price target to $7. On December 10, 2018, Northland Capital initiated with a Outperform rating and assigned a price target of $7 on the stock. Rodman & Renshaw reiterated its Buy rating and increased its price target to $12 on May 16, 2017.
The stock price of STRATA Skin Sciences Inc [SSKN] has been fluctuating between $1.38 and $3.86 over the past year. STRATA Skin Sciences Inc [NASDAQ: SSKN] shares were valued at $2.08 at the most recent close of the market.
Analyzing the SSKN fundamentals
The STRATA Skin Sciences Inc [NASDAQ:SSKN] reported sales of 32.85M for trailing twelve months, representing a drop of -9.15%. Gross Profit Margin for this corporation currently stands at 0.58% with Operating Profit Margin at -0.31%, Pretax Profit Margin comes in at -0.36%, and Net Profit Margin reading is -0.35%. To continue investigating profitability, this company’s Return on Assets is posted at -0.38, Equity is -2.67 and Total Capital is -0.61. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of3.52.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.89 points at the first support level, and at 1.71 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.24, and for the 2nd resistance point, it is at 2.41.
Ratios To Look Out For
It’s worth pointing out that STRATA Skin Sciences Inc [NASDAQ:SSKN]’s Current Ratio is 0.98. In addition, the Quick Ratio stands at 0.75 and the Cash Ratio stands at 0.43. Considering the valuation of this stock, the price to sales ratio is 0.33, the price to book ratio is 28.17.
